- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02168348
Impact of Malnutrition on the Healing of Foot Lesions in Diabetic Patients
May 3, 2019 updated by: Centre Hospitalier Universitaire Dijon
The investigators set out to determine whether malnutrition delayed healing of foot lesions in diabetic patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
75
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Dijon, France, 21079
- CHU de Dijon
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients with type 1 or 2 diabetes who have a lesion situated on a toe or on the plantar or dorsal side of the foot
Description
Inclusion Criteria:
- Patients who have provided oral consent
- Patients older than 18
- Patients with type 1 or 2 diabetes
- Patients who can be followed-up in the context of consultations for diabetic foot at the endocrinology, diabetology and metabolic diseases unit of Dijon CHU.
- Lesion situated on a toe or on the plantar or dorsal side of the foot
- Lesion that has evolved for 1 to 24 months
Exclusion Criteria:
- Adult under guardianship
- Patient without national health insurance
- Pregnant or breast-feeding women
- Patients with progressive cancer
- Patients with terminal renal insufficiency on dialysis
- Patient with severe respiratory insufficiency
- Patients with terminal heart failure
- Patients with severe liver failure
- Patients with immunodepriession (treatement with immunosuppressants, long-term corticotherapy, diseases leading to immunodepression)
- Patients with nephrotic syndrome (hypoalbuminemia)
- Patientswith a chronic inflammatory syndrome
- Alcohol consumption greater than 4 glasses per day
- Systemic infection uncontrolled by antibiotics
- Infected lesion with systemic repercussions
- Charcot foot
- Patients taking part or who have planned to take part in another clinical trial
- Severe disease affecting survival in the short term
- Lesion on an amputation
- Lesion of the ankle or leg
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Diabetic patients with a lesion on the foot
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percentage of healed lesions
Time Frame: After 24 weeks of follow-up
|
After 24 weeks of follow-up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of malnourished patients according to HAS 2003 and 2007 criteria
Time Frame: At inclusion
|
At inclusion
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percentage of healed lesions during the follow-up
Time Frame: At 2, 4, 8, 12, 16 and 20 weeks
|
At 2, 4, 8, 12, 16 and 20 weeks
|
Number of malnourished patients at 12 and 24 weeks
Time Frame: At 12 and 24 weeks
|
At 12 and 24 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 26, 2013
Primary Completion (Actual)
January 17, 2017
Study Registration Dates
First Submitted
June 18, 2014
First Submitted That Met QC Criteria
June 19, 2014
First Posted (Estimate)
June 20, 2014
Study Record Updates
Last Update Posted (Actual)
May 6, 2019
Last Update Submitted That Met QC Criteria
May 3, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BOUILLET 2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients With Type 1 or 2 Diabetes
-
Centre Hospitalier Universitaire DijonTerminatedPatients With Type 1 or Type 2 Diabetes | Patients With a Type A or B Behaviour ProfileFrance
-
Yanbing LiNot yet recruitingEfficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients | Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect | 128 Patients Were Randomly Assigned 1:1 | Metformin and Insulin Glargine Combined... and other conditionsChina
-
Solvay PharmaceuticalsCompleted
-
Assistance Publique - Hôpitaux de ParisUnknownPatients With Type 1 DiabetesFrance
-
Seoul National University HospitalCompletedPatients With Type 2 DiabetesKorea, Republic of
-
Cairo UniversityNot yet recruitingDiabetic Pediatric Patients With Type 1 Diabetes
-
AstraZenecaCompletedAdult Patients With Type 2 Diabetes MellitusKorea, Republic of
-
Massachusetts General HospitalBeta Bionics, Inc.WithdrawnType 1 Diabetes | Type 2 Diabetes Treated With InsulinUnited States
-
University of California, IrvineWithdrawnAnesthetized Healthy Patients (ASA 1 or 2) in the Supine Position, Excluding Head, Neck and Head Surgeries | Anesthetized Patient With Severe Systemic Disease (ASA 3 or 4)United States
-
Eli Lilly and CompanyRecruitingType 1 Diabetes | Type 2 Diabetes | Type 2 Diabetes Treated With InsulinFrance
Clinical Trials on biological examination at consultations at 3 and 6 months
-
Centre Hospitalier Universitaire DijonCompletedInfectious Disease | Solid Tumor | Hemopathy | Horton's Disease | NeoplasiaFrance
-
Hawler Medical UniversityCompleted
-
Cardiff UniversityPodiatry Department, Cardiff & Vale University Health Board; School of Health... and other collaboratorsUnknownChronic Kidney DiseaseUnited Kingdom
-
Association Francaise pour la Recherche ThermaleCompleted
-
Rennes University HospitalRecruiting
-
Norfolk and Norwich University Hospitals NHS Foundation...University of East AngliaCompleted
-
Centre Hospitalier Universitaire, AmiensCompletedMorality | Femur FractureFrance
-
Azienda Ospedaliero-Universitaria CareggiCompletedRecurrent Angina After Coronary Stent Placement
-
Hospices Civils de LyonRecruiting
-
University Hospital, AngersNot yet recruiting